BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 17056458)

  • 41. Uterine perforation in women using a levonorgestrel-releasing intrauterine system.
    Van Houdenhoven K; van Kaam KJ; van Grootheest AC; Salemans TH; Dunselman GA
    Contraception; 2006 Mar; 73(3):257-60. PubMed ID: 16472566
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Predictors of oligoamenorrhea at 1-year follow-up in premenopausal women using a levonorgestrel-releasing intrauterine system.
    de Jonge ET; Yigit R; Molenberghs G; Straetmans D; Ombelet W
    Contraception; 2007 Aug; 76(2):91-5. PubMed ID: 17656176
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serum levonorgestrel levels and endometrial thickness during extended use of the levonorgestrel-releasing intrauterine system.
    Hidalgo MM; Hidalgo-Regina C; Bahamondes MV; Monteiro I; Petta CA; Bahamondes L
    Contraception; 2009 Jul; 80(1):84-9. PubMed ID: 19501221
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transurethral use of a nephroscope significantly AIDS in the surgical management of an intrauterine device eroding into the bladder.
    Scovell JM; Chan RC; Smith CP
    Female Pelvic Med Reconstr Surg; 2014; 20(6):e8-11. PubMed ID: 25185606
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bladder stone: a complication of intravesical migration of Lippes loop.
    el-Diasty TA; Shokeir AA; el-Gharib MS; Sherif LS; Shamaa MA
    Scand J Urol Nephrol; 1993; 27(2):279-80. PubMed ID: 8351486
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cervical perforation by the strings of a levonorgestrel releasing-intrauterine system: a case report.
    Gönenç I; Vural EZ; Aka N
    Eur J Contracept Reprod Health Care; 2013 Oct; 18(5):415-8. PubMed ID: 23937289
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Subject and clinician experience with the levonorgestrel-releasing intrauterine system.
    Jensen JT; Nelson AL; Costales AC
    Contraception; 2008 Jan; 77(1):22-9. PubMed ID: 18082662
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Hysteroscopy to relieve IUD-related symptoms].
    de Groot PC; Kapiteijn K; Siemans F
    Ned Tijdschr Geneeskd; 2010; 154():A2298. PubMed ID: 21176259
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Does an intraabdominally placed LNG-IUS have an adverse effect on fertility? A case report.
    Doris N; Shabib G; Corbett S; Leader A; Black A
    Contraception; 2014 Jan; 89(1):63-6. PubMed ID: 24156885
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Management of levonorgestrel-releasing intrauterine system (LNG-IUS) uterine perforation.
    Margarit LM; Griffiths AN; Vine SJ
    J Obstet Gynaecol; 2004 Aug; 24(5):586-7. PubMed ID: 15369954
    [No Abstract]   [Full Text] [Related]  

  • 51. Surgical removal of an intrauterine device perforating the sigmoid colon: a case report.
    Mederos R; Humaran L; Minervini D
    Int J Surg; 2008 Dec; 6(6):e60-2. PubMed ID: 17409036
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intrauterine devices and intrauterine systems.
    ESHRE Capri Workshop Group
    Hum Reprod Update; 2008; 14(3):197-208. PubMed ID: 18400840
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intrauterine devices and adolescents.
    Gold MA; Johnson LM
    Curr Opin Obstet Gynecol; 2008 Oct; 20(5):464-9. PubMed ID: 18797269
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Experience with the levonorgestrel-releasing intrauterine system among HIV-infected women.
    Lehtovirta P; Paavonen J; Heikinheimo O
    Contraception; 2007 Jan; 75(1):37-9. PubMed ID: 17161122
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intravesical Weck clip migration after laparoscopic radical prostatectomy.
    Banks EB; Ramani A; Monga M
    Urology; 2008 Feb; 71(2):351.e3-4. PubMed ID: 18308120
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bladder stone in a human female: the case of an abnormally located intrauterine contraceptive device.
    Khan SR; Wilkinson EJ
    Scanning Microsc; 1990 Jun; 4(2):395-8. PubMed ID: 2402612
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Uterine perforation and localization of an IUD in the bladder associated with bladder calculosis. Report of a case and review of the literature].
    Reyes-Acevedo J; Bustamante-Sarabia J; Galindo-Martínez DF
    Ginecol Obstet Mex; 1995 Oct; 63():407-9. PubMed ID: 8549921
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Squamous cell carcinoma of the bladder associated with chronic irritation related to a migrated intrauterine device.
    Gökce MI; Süer E; Tangal S; Bedük Y
    Scand J Urol Nephrol; 2010 Apr; 44(3):183-5. PubMed ID: 20367452
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Effects of levonorgestrel-releasing intrauterine system on pain and recurrence associated with endometriosis and adenomyosis].
    Deng S; Lang JH; Leng JH; Liu ZF; Sun DW; Zhu L
    Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):664-8. PubMed ID: 17199919
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of the levonorgestrel-releasing intrauterine system in women with hemostatic disorders.
    Lukes AS; Reardon B; Arepally G
    Fertil Steril; 2008 Sep; 90(3):673-7. PubMed ID: 18001734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.